Taylor Financial Group’s Pfizer PFE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$355K Hold
14,740
0.2% 81
2026
Q1
$414K Buy
14,740
+1,000
+7% +$26.6K 0.25% 73
2025
Q4
$342K Hold
13,740
0.2% 82
2025
Q3
$350K Sell
13,740
-66
-0.5% -$1.63K 0.2% 82
2025
Q2
$335K Buy
13,806
+2,815
+26% +$65.6K 0.21% 79
2025
Q1
$279K Sell
10,991
-2,000
-15% -$52.3K 0.19% 81
2024
Q4
$345K Sell
12,991
-716
-5% -$19.4K 0.24% 74
2024
Q3
$397K Sell
13,707
-468
-3% -$13.7K 0.27% 71
2024
Q2
$397K Buy
14,175
+2,699
+24% +$74.3K 0.3% 67
2024
Q1
$318K Buy
11,476
+717
+7% +$19.9K 0.24% 72
2023
Q4
$310K Buy
+10,759
New +$325K 0.25% 72

Other funds holding PFE

Taylor Financial Group's PFE Position: Q2 2026 in Review

Taylor Financial Group held its Pfizer (PFE) position steady in Q2 2026 at 14,740 shares worth $355K. The position accounts for 0.2% of the portfolio, ranked #81.

Taylor Financial Group first reported a position in PFE in Q4 2023 and has held it in 11 quarters since. The position peaked at $414K in Q1 2026. 1,199 funds tracked by Wall St. Rank hold PFE as of Q2 2026.

  • Taylor Financial Group held 14,740 shares of Pfizer worth $355K as of Q2 2026.
  • Taylor Financial Group left its Pfizer share count unchanged in Q2 2026.
  • Pfizer made up 0.2% of Taylor Financial Group's portfolio in Q2 2026, its #81 holding.
  • Taylor Financial Group first reported a position in Pfizer in Q4 2023 and has held it in 11 quarters since.
  • Taylor Financial Group's Pfizer position peaked at $414K in Q1 2026.
  • 1,199 funds tracked by Wall St. Rank held Pfizer as of Q2 2026.

Based on Taylor Financial Group's 13F filing for Q2 2026, filed 24 Jul 2026.